STOCK TITAN

RSU vesting adds shares for Zoetis (NYSE: ZTS) director Paul Bisaro

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Zoetis Inc. director Paul Bisaro acquired common stock through the vesting and settlement of restricted stock units. On February 19, 2026, 1,619.3325 RSUs were exercised or converted, resulting in the acquisition of 1,619 shares of Zoetis common stock at a stated price of $0.00 per share.

After these transactions, he directly owned 25,862 shares of Zoetis common stock. He also held 1,936 restricted stock units, each representing a contingent right to receive one share of Zoetis common stock, which are scheduled to vest and settle on the first anniversary of their grant date, February 18, 2026, subject to continued service and certain earlier vesting events.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Bisaro Paul

(Last) (First) (Middle)
C/O ZOETIS INC.
10 SYLVAN WAY

(Street)
PARSIPPANY NJ 07054

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Zoetis Inc. [ ZTS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
02/19/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 02/19/2026 M 1,619 A (1) 25,862 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Unit(2) (3) 02/19/2026 M 1,619.3325 (4) (5) Common Stock 1,619.3325 (1) 0 D
Restricted Stock Unit(2) (3) (6) (5) Common Stock 1,936 1,936 D
Explanation of Responses:
1. Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.
2. Represents restricted stock units granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs").
3. Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock.
4. Each RSU vests and is settled in shares of Zoetis Inc. common stock on the first anniversary of the date of grant, February 19, 2025.
5. Not applicable.
6. Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first anniversary of the date of grant, February 18, 2026; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.
Remarks:
/s/ Brenda Santuccio, as Attorney-in-Fact 02/23/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Zoetis (ZTS) director Paul Bisaro report?

Zoetis director Paul Bisaro reported acquiring shares through restricted stock unit vesting and settlement. On February 19, 2026, RSUs were exercised or converted, delivering 1,619 shares of common stock at a stated price of $0.00 per share as part of his equity compensation.

How many Zoetis (ZTS) shares did Paul Bisaro receive from RSU vesting?

Paul Bisaro received 1,619 shares of Zoetis common stock upon vesting and settlement of restricted stock units. These shares came from the exercise or conversion of 1,619.3325 RSUs, each representing a right to receive one Zoetis common share upon vesting under the company’s equity plan.

What is Paul Bisaro’s Zoetis (ZTS) common stock holding after this Form 4?

After the reported transactions, Paul Bisaro directly owned 25,862 shares of Zoetis common stock. This figure reflects his updated direct ownership following the RSU vesting and share delivery and indicates his ongoing equity stake as a director of Zoetis Inc.

What do the Zoetis (ZTS) restricted stock units held by Paul Bisaro represent?

Each restricted stock unit represents a contingent right to receive one share of Zoetis common stock. The RSUs were granted under the Zoetis Amended and Restated 2013 Equity and Incentive Plan and include associated dividend equivalent units that are automatically issued on the underlying RSUs.

When will Paul Bisaro’s remaining Zoetis (ZTS) RSUs vest and settle?

Each remaining RSU will vest and be settled in Zoetis common stock on the first anniversary of its grant date, February 18, 2026. Vesting is subject to Paul Bisaro’s continued service through that date and may accelerate upon certain specified events described in the award terms.

How many Zoetis (ZTS) restricted stock units does Paul Bisaro hold after the transaction?

Following the reported activity, Paul Bisaro held 1,936 restricted stock units. Each unit corresponds to a contingent right to receive one Zoetis common share, scheduled to vest and settle on February 18, 2026, assuming continued service and subject to specific early vesting conditions.
Zoetis Inc

NYSE:ZTS

View ZTS Stock Overview

ZTS Rankings

ZTS Latest News

ZTS Latest SEC Filings

ZTS Stock Data

48.94B
421.44M
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
PARSIPPANY